ASCO GI 2021 | Impact of COVID-19 on the regulatory approval process

Lola A. Fashoyin-Aje, MD, MPH, U.S. Food and Drug Administration, outlines how the COVID-19 pandemic has impacted the trials and approvals process and what adaptations have been implemented by the FDA, with the importance of preserving the safety of patients. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).